Pneumococcal conjugate second or third-dose vaccines (PCVc) immunizati in Saudi Arabia
Saudi Arabia: Pneumococcal conjugate second or third-dose vaccines (PCVc) immunizati was 98.0% in 2025. ▲ Rising
Pneumococcal conjugate second or third-dose vaccines (PCVc) immunizati in Saudi Arabia, 2008–2025
Source: World Health Organization, Global Health Observatory.
Analysis
The most recent figure for pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati in Saudi Arabia is 98.0%, measured in 2025. That is the highest value across all 18 years on record.
Compared with earlier readings it is up 2.1% on the previous year and unchanged over ten years.
Over the whole period, pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati in Saudi Arabia peaked at 98.0% in 2009 and was at its lowest, 0.0%, in 2008.
Saudi Arabia ranks 11th of 194 countries on this measure, in the top 10%.
The long-run direction has been consistently rising across the 18 years of available data.
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 49.0% | 0.0% | 98.0% | 2 |
| 2010s | 97.8% | 96.0% | 98.0% | 10 |
| 2020s | 96.8% | 95.0% | 98.0% | 6 |
Countries ranked near Saudi Arabia
- 11 Turkmenistan 98.0% compare
- 11 El Salvador 98.0% compare
- 11 Portugal 98.0% compare
- 11 Costa Rica 98.0% compare
- 11 Mauritius 98.0% compare
More health data for Saudi Arabia
- Un projection of annual infant deaths 829 (2100)
- Heat deaths vs projected death rates 483.6 (2090)
- Deaths in armed conflicts by country 4 (2026)
- Deaths in armed conflicts by region 4 (2026)
- Age population, age 17, female, interpolated 240,758 (2025)
- Population ages 15-64, male 77.3% (2025)
- Age population, age 18, male, interpolated 256,303 (2025)
- Age population, age 18, female, interpolated 236,467 (2025)
- Age population, age 17, male, interpolated 254,137 (2025)
- Age population, age 16, female, interpolated 245,267 (2025)
Frequently asked questions
- What is pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati in Saudi Arabia?
- Pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati in Saudi Arabia was 98.0% in 2025, according to World Health Organization, Global Health Observatory.
- What is the highest pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati recorded in Saudi Arabia?
- The highest recorded value was 98.0% in 2009.
- What is the lowest pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati recorded in Saudi Arabia?
- The lowest recorded value was 0.0% in 2008.
- How does Saudi Arabia rank for pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati?
- Saudi Arabia ranks 11th out of 194 countries with data for 2025.
- Is pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati rising or falling in Saudi Arabia?
- Over the last ten years it is unchanged. The long-run trend across the full record is rising.
- Where does this Saudi Arabia data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Pneumococcal conjugate second or third-dose vaccines (PCVc) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 18 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).